Echocardiographic Progression of Calcific Aortic Valve Disease in Patients with Preexisting Aortic Valve Sclerosis
暂无分享,去创建一个
M. Kelm | G. Nickenig | V. Mauri | S. Baldus | M. Kelm | V. Veulemans | A. Sugiura | A. Sedaghat | Matti Adam | B. Al-Kassou | J. Shamekhi | S. Zimmer | M. Weber | N. Wilde | C. Uehre | G. Nickenig | Stephan Baldus | Carina Uehre
[1] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[2] M. Dweck,et al. Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy. , 2020, Cardiology clinics.
[3] Eric J Velazquez,et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[4] H. Crijns,et al. Calcific aortic valve stenosis: hard disease in the heart , 2017, European heart journal.
[5] D. Rader,et al. Biomarkers of Calcific Aortic Valve Disease , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[6] Michael J.A. Williams,et al. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. , 2014, Journal of the American College of Cardiology.
[7] B. Iung,et al. Degenerative calcific aortic stenosis: a natural history , 2012, Heart.
[8] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[9] K. J. Grande-Allen,et al. Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .
[10] R. Sainger,et al. Insights into the use of biomarkers in calcific aortic valve disease. , 2010, The Journal of heart valve disease.
[11] K. Teo,et al. Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.
[12] J. Chambers,et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.
[13] M. Enriquez-Sarano,et al. Aortic Valve Calcification: Determinants and Progression in the Population , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[14] Rosario V. Freeman,et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.
[15] R. Prescott,et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.
[16] P. Faggiano,et al. Progression of aortic valve sclerosis to aortic stenosis. , 2003, The American journal of cardiology.
[17] M. Enriquez-Sarano,et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. , 2002, Journal of the American College of Cardiology.
[18] I. Kronzon,et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. , 2002, Archives of internal medicine.
[19] Bonnie K. Lind,et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.
[20] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[21] J. Lodder,et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve , 1997, Heart.
[22] Bonnie K. Lind,et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.
[23] T. Strandberg,et al. Factors associated with calcific aortic valve degeneration in the elderly. , 1994, European heart journal.
[24] C. Otto,et al. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. , 1989, Journal of the American College of Cardiology.
[25] W. Aronow,et al. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. , 1987, The American journal of cardiology.